ITOS
Two Sigma Advisers’s iTeos Therapeutics ITOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $179K | Buy |
+18,000
| New | +$179K | ﹤0.01% | 2141 |
|
|
2024
Q4 | – | Sell |
-37,900
| Closed | -$387K | – | 2432 |
|
|
2024
Q3 | $387K | Buy |
37,900
+19,700
| +108% | +$201K | ﹤0.01% | 1813 |
|
|
2024
Q2 | $270K | Buy |
+18,200
| New | +$270K | ﹤0.01% | 2113 |
|
|
2022
Q4 | – | Sell |
-86,200
| Closed | -$1.64M | – | 2609 |
|
|
2022
Q3 | $1.64M | Sell |
86,200
-69,000
| -44% | -$1.31M | ﹤0.01% | 1271 |
|
|
2022
Q2 | $3.2M | Sell |
155,200
-75,900
| -33% | -$1.56M | 0.01% | 973 |
|
|
2022
Q1 | $7.44M | Buy |
231,100
+51,100
| +28% | +$1.64M | 0.02% | 639 |
|
|
2021
Q4 | $8.38M | Buy |
180,000
+62,400
| +53% | +$2.91M | 0.02% | 562 |
|
|
2021
Q3 | $3.18M | Buy |
117,600
+78,900
| +204% | +$2.13M | 0.01% | 1011 |
|
|
2021
Q2 | $993K | Buy |
+38,700
| New | +$993K | ﹤0.01% | 1643 |
|